Managed by NetworkPharma

Managed by
NetworkPharma

Facilitating Networking and Information Sharing amongst Pharmaceutical and MedComms, Medical Communications, Medical Education and Medical Publishing Specialists

For 18 years, this global initiative has facilitated networking and dialogue amongst individuals working in and around the pharmaceutical industry and MedComms, focusing on specialist medical education, medical communications and medical publishing activities.
Please join the conversation on LinkedIn, using hashtag #MedComms.

MORE DETAILS

  • Home
  • About us
  • Events
  • In the News
  • Companies
  • Independents
  • Services
  • Job Adverts
  • Webcasts
  • Starting out
  • Survey data
  • Sponsors

  • This event is free of charge to any members of this MedComms Networking Community.

    If you would like to attend, just email Peter Llewellyn.

    Please note the plan is for a maximum 20 participants and we restrict attendance to a maximum of two individuals per agency. If more than 20 names are listed, then email and ask to be added to the waiting list.


    Join the conversation on LinkedIn. Use hashtag #MedComms


    MedComms Networking is sponsored by:

    Many thanks to all the Sponsors of MedComms Networking

    BRUNCH AND LEARN - 21 AUGUST 2015 - OXFORD

    What's new in GPP3? Presentation and workshop

    The updated Good Publication Practice (GPP) guideline, known as GPP3 has now been published and we were delighted to have the opportunity to hear about the details from Liz Wager, Publications Consultant and Co-Author of the new paper. Liz was also co-author of the original guideline in 2003 so was well placed to reflect on the changing landscape in publications management. Webcast and slides are provided below.

    Battisti WP, Wager E, Baltzer L, Bridges D, Cairns A, Carswell CI, et al. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3. Ann Intern Med. [Epub ahead of print 11 August 2015] doi:10.7326/M15-0288

    "This updated Good Publication Practice (GPP) guideline, known as GPP3, builds on earlier versions and provides recommendations for individuals and organizations that contribute to the publication of research results sponsored or supported by pharmaceutical, medical device, diagnostics, and biotechnology companies. The recommendations are designed to help individuals and organizations maintain ethical and transparent publication practices and comply with legal and regulatory requirements. These recommendations cover publications in peer-reviewed journals and presentations (oral or poster) at scientific congresses. The International Society for Medical Publication Professionals invited more than 3000 professionals worldwide to apply for a position on the steering committee, or as a reviewer, for this guideline. The GPP2 authors reviewed all applications (n = 241) and assembled an 18-member steering committee that represented 7 countries and a diversity of publication professions and institutions. From the 174 selected reviewers, 94 sent comments on the second draft, which steering committee members incorporated after discussion and consensus."

    Date: 21 August 2015

    Venue: Magdalen Centre, The Oxford Science Park, Robert Robinson Avenue, Oxford OX4 4GE [DIRECTIONS]

    WEBCAST:

    PRESENTATION SLIDES:

    [Download the slides here]

    PHOTOS:

    Liz Wager, What's new in GPP3, 21 August 2015, MedComms Networking event

    Liz Wager, What's new in GPP3, 21 August 2015, MedComms Networking event

    Liz Wager, What's new in GPP3, 21 August 2015, MedComms Networking event

    To make sure you're included in announcements about future events just email Peter Llewellyn, if you haven't already done so, to register your interest.

    WHAT ELSE?

    This meeting is free to attend thanks to the generosity of the corporate sponsors.


    This workshop was led by Liz Wager, Publications Consultant, Sideview.

    Dr Elizabeth (Liz) Wager has worked with scientists, editors and writers on six continents. Before setting up Sideview she worked in the publishing and pharmaceutical industries (for Blackwell Scientific, Janssen Cilag and GlaxoSmithKline). She chaired the Committee on Publication Ethics (2009-12) and is a member of the BMJ's Ethics Committee, the World Association of Medical Editors Ethics Committee, and the CONSORT for Abstracts steering group. She is Visiting Professor at the University of Split School of Medicine.

    She is a co-author of Good Publication Practice for Pharmaceutical Companies (2003 and GPP3, 2015), the European Medical Writers Association guidelines on the role of medical writers (2005), the Wiley-Blackwell Best Practice Guidelines on Publication Ethics (2006), COPE Best Practice and flowcharts for journal editors and the author of books on 'Getting Research Published: an A to Z of Publication Strategy' (2nd edition 2010) and 'How to Survive Peer Review'. She has published research and commentaries on peer review and is the co-author of two systematic reviews on the effects of peer review. In 2010 she was awarded a PhD for a thesis entitled 'Peer review and editorial processes for improving the quality of research reporting'.

    Elizabeth (Liz) Wager, Publications Consultant, Sideview

    Companies
    attending
    included:

    7.4 Limited
    Aspire Scientific
    Caudex
    Elements Communications
    Fishawack Communications
    GeoMed
    Highfield Communication
    inVentiv Medical Communications
    iS LifeScience
    NexGen Healthcare Communications
    Watermeadow Medical


    This web site and associated activities are being managed by NetworkPharma Ltd, company registration 4392836
    Registered office: 6-7 Citibase, New Barclay House, 234 Botley Road, Oxford, OX2 0HP, UK Email: support@networkpharma.com